These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2376002)
21. Protein kinase C--a potential modifier of carotid body function. Faff L; Kowalewski C; Pokorski M Monaldi Arch Chest Dis; 1999 Apr; 54(2):172-7. PubMed ID: 10394835 [TBL] [Abstract][Full Text] [Related]
22. Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea-pig lung parenchyma. Lebel N; D'Orléans-Juste P; Fournier A; Sirois P Br J Pharmacol; 1996 Jan; 117(1):184-8. PubMed ID: 8825361 [TBL] [Abstract][Full Text] [Related]
23. Potential role of H2O2 in chemoreception in the cat carotid body. Osanai S; Mokashi A; Rozanov C; Buerk DG; Lahiri S J Auton Nerv Syst; 1997 Mar; 63(1-2):39-45. PubMed ID: 9089537 [TBL] [Abstract][Full Text] [Related]
25. Vascular A10 cell membranes contain an endothelin metabolizing neutral endopeptidase. Dickinson KE; Tymiak AA; Cohen RB; Liu EC; Webb ML; Hedberg A Biochem Biophys Res Commun; 1991 Apr; 176(1):423-30. PubMed ID: 2018530 [TBL] [Abstract][Full Text] [Related]
26. Kidney neutral endopeptidase and the hydrolysis of enkephalin by synaptic membranes show similar sensitivity to inhibitors. Fulcher IS; Matsas R; Turner AJ; Kenny AJ Biochem J; 1982 May; 203(2):519-22. PubMed ID: 7052059 [TBL] [Abstract][Full Text] [Related]
27. Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon. Oefner C; D'Arcy A; Hennig M; Winkler FK; Dale GE J Mol Biol; 2000 Feb; 296(2):341-9. PubMed ID: 10669592 [TBL] [Abstract][Full Text] [Related]
28. Carotid body chemoreception: the importance of CO2-HCO3- and carbonic anhydrase. (review). Iturriaga R Biol Res; 1993; 26(3):319-29. PubMed ID: 7606251 [TBL] [Abstract][Full Text] [Related]
29. Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme. Kukkola PJ; Savage P; Sakane Y; Berry JC; Bilci NA; Ghai RD; Jeng AY J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S65-8. PubMed ID: 8587470 [TBL] [Abstract][Full Text] [Related]
30. The neural pathway involved in "efferent inhibition" of chemoreceptors in the cat carotid body. McDonald DM; Mitchell RA J Comp Neurol; 1981 Sep; 201(3):457-76. PubMed ID: 7276260 [TBL] [Abstract][Full Text] [Related]
32. Characterization of neutral endopeptidase 24.11 in dog glomeruli. Landry C; Santagata P; Bawab W; Fournié-Zaluski MC; Roques BP; Vinay P; Crine P Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):773-9. PubMed ID: 8489505 [TBL] [Abstract][Full Text] [Related]
33. The increased proliferation of cultured neuroblastoma cells treated with vasoactive intestinal peptide is enhanced by simultaneous inhibition of neutral endopeptidase. Wollman Y; Blumberg S; Spungin A; Brenneman DE; Fridkin M; Wollman J; Iaina A; Gozes I Regul Pept; 2002 Oct; 108(2-3):175-7. PubMed ID: 12220742 [TBL] [Abstract][Full Text] [Related]
34. Neural responses of the cat carotid and aortic bodies to hypercapnia and hypoxia. Fitzgerald RS; Dehghani GA J Appl Physiol Respir Environ Exerc Physiol; 1982 Mar; 52(3):596-601. PubMed ID: 7068474 [TBL] [Abstract][Full Text] [Related]